Provenance du réseau au premier degré de Dieter Hauwaerts
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dieter Hauwaerts via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Université Catholique de Louvain | College/University | Undergraduate Degree Graduate Degree | |
| ICHEC | College/University | Graduate Degree | |
| Université de Namur ASBL | College/University | Graduate Degree | |
Dow Silicones Belgium SRL
 Dow Silicones Belgium SRL Industrial SpecialtiesProcess Industries Part of Dow, Inc., Dow Silicones Belgium SRL manufactures sealants. The company is based in Seneffe, Belgium. | Industrial Specialties | Human Resources Officer | |
Fourcroy SA
 Fourcroy SA Food DistributorsDistribution Services Fourcroy SA wholesales wine and distilled beverages. Fourcroy distributor of this broad portfolio of wines and spirits in Belgium and the Grand Duchy of Luxembourg may rely on the experience and innovative ideas. The company was founded in 1862 and is headquartered in Braine-L'Alleud, Belgium. | Food Distributors | Corporate Officer/Principal | |
Cellular Therapeutics Ltd.
 Cellular Therapeutics Ltd. BiotechnologyHealth Technology Part of Instil Bio, Inc., Cellular Therapeutics Ltd. is a British company that manufactures cell therapy products. The company is based in Manchester, UK. The company was founded by David Gilham. | Biotechnology | Founder | |
| University Of Dundee | College/University | Doctorate Degree | |
AstraZeneca NV
 AstraZeneca NV Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, AstraZeneca NV operates as a Belgian biopharmaceutical company. The company is based in Groot Bijgaarden, Belgium. AstraZeneca was founded in 1999. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| University of South Florida | College/University | Undergraduate Degree | |
| Coventry University | College/University | Undergraduate Degree | |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | General Counsel | |
| AURA BIOSCIENCES, INC. | Biotechnology | General Counsel | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | General Counsel | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| University of Aberystwyth | College/University | Doctorate Degree | |
| VOLCANO CORPORATION | Medical Specialties | Corporate Officer/Principal | |
Aniserco NV (Flemish Region)
 Aniserco NV (Flemish Region) Specialty StoresRetail Trade Aniserco NV is a private company based in Dilbeek, Belgium. Aniserco NV operates under the brand name Tom&Co, offering a wide range of high-quality pet products, including food, grooming accessories, toys, and litter, among others. The Belgian company provides a practical click & collect service and fast delivery to take care of pets. With trusted brand products and expert advice, Tom&Co is an ideal partner for pet owners to take care of their faithful companions. The company was founded in 1991, and Thierry Le Grelle has been the CEO of the company since 2022. | Specialty Stores | Director/Board Member | |
World Heart Federation
 World Heart Federation Miscellaneous Commercial ServicesCommercial Services World Heart Federation is a global organization dedicated to the treatment, prevention, and control of cardiovascular disease. The non-profit company is based in Geneva, Switzerland and was founded by James Leslie Cox. The Swiss company is formally recognized by the World Health Organization as their CVD partner and represent more than 200 members from over 100 countries. The company's mission is to raise awareness and support research efforts for Chagas disease, which can cause life-changing problems for sufferers. The company has members all across Central Asia and work closely with international partners. The company welcomes heart professionals, NGOs, patients, and more to join their community. | Miscellaneous Commercial Services | Director/Board Member | |
PetSerCo BV
 PetSerCo BV Financial ConglomeratesFinance PetSerCo BV operates as an investment vehicle. The company is headquartered in Wavre, Belgium. | Financial Conglomerates | Director/Board Member | |
| SOLVAY SA | Chemicals: Specialty | General Counsel | |
Linklaters de Bandt
 Linklaters de Bandt Miscellaneous Commercial ServicesCommercial Services Part of Linklaters LLP, Linklaters de Bandt is a Belgian company that provides legal services. The company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Université Libre de Bruxelles | College/University | Graduate Degree | |
| Harvard Law School | College/University | Graduate Degree | |
| DELHAIZE GROUP | Food Retail | General Counsel | |
| Advanced Therapies Consulting Limited | Chief Executive Officer | ||
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
| Ghent University | College/University | Doctorate Degree | |
| European Association of Percutaneous Cardiovascular Intervent | Corporate Officer/Principal | ||
| Cardiovascular Center Aalst | Director/Board Member | ||
| The European Society of Cardiology | Director/Board Member | ||
| Price Waterhouse Coopers | Corporate Officer/Principal |
Statistiques
Internationale
| Belgique | 18 |
| Etats-Unis | 9 |
| Royaume-Uni | 7 |
| Suisse | 2 |
| France | 2 |
Sectorielle
| Consumer Services | 11 |
| Health Technology | 10 |
| Commercial Services | 4 |
| Process Industries | 3 |
| Retail Trade | 3 |
Opérationnelle
| Corporate Officer/Principal | 10 |
| General Counsel | 9 |
| Director/Board Member | 6 |
| Graduate Degree | 6 |
| Founder | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Dieter Hauwaerts
- Connexions Sociétés
